Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-17

Clinical Trial Update: Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion [Phase 3]

View source ↗

Summary

Phase 3 trial assessing isosorbide mononitrate to reduce pain during levonorgestrel-releasing IUD insertion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isosorbide Mononitrate (isosorbide mononitrate)
  • Levonorgestrel-Releasing Intrauterine System (levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: Cairo University | Conditions: Contraception | Phase 3 | Status: UNKNOWN